Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Mk-2048
2. 869901-69-9
3. Mk2048
4. Mk 2048
5. Lj8u884tm5
6. (s)-2-(3-chloro-4-fluorobenzyl)-8-ethyl-10-hydroxy-n,6-dimethyl-1,9-dioxo-1,2,6,7,8,9-hexahydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide
7. Pyrazino(1',2':1,5)pyrrolo(2,3-d)pyridazine-4-carboxamide, 2-((3-chloro-4-fluorophenyl)methyl)-8-ethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-n,6-dimethyl-1,9-dioxo-, (6s)-
8. Unii-lj8u884tm5
9. 3oyl
10. 3oyn
11. Zzx
12. Schembl3984882
13. Chembl1237018
14. Dtxsid70236031
15. Bcp03947
16. Ex-a2340
17. Zinc35801891
18. Bcp9000947
19. Ccg-269361
20. Cs-1034
21. Mk 2048;mk2048
22. Ncgc00346694-01
23. Ncgc00346694-02
24. Ncgc00346694-03
25. Ncgc00346694-04
26. Hy-13305
27. Bcp0726000130
28. Q3273019
29. (13s)-5-[(3-chloro-4-fluorophenyl)methyl]-11-ethyl-8-hydroxy-n,13-dimethyl-6,10-dioxo-1,4,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,8-triene-3-carboxamide
30. (6s)-2-((3-chloro-4-fluorophenyl)methyl)-8-ethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-n,6-dimethyl-1,9-dioxopyrazino(1',2':1,5)pyrrolo(2,3-d)pyridazine-4-carboxamide
31. (6s)-2-[(3-chloro-4-fluoro-phenyl)methyl]-8-ethyl-10-hydroxy-n,6-dimethyl-1,9-dioxo-6,7-dihydropyrazino[[?]:[?]]pyrrolo[[?]]pyridazine-4-carboxamide
| Molecular Weight | 461.9 g/mol |
|---|---|
| Molecular Formula | C21H21ClFN5O4 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 461.1266100 g/mol |
| Monoisotopic Mass | 461.1266100 g/mol |
| Topological Polar Surface Area | 107 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 828 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Mk2048 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mk2048, including repackagers and relabelers. The FDA regulates Mk2048 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mk2048 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mk2048 supplier is an individual or a company that provides Mk2048 active pharmaceutical ingredient (API) or Mk2048 finished formulations upon request. The Mk2048 suppliers may include Mk2048 API manufacturers, exporters, distributors and traders.
click here to find a list of Mk2048 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mk2048 DMF (Drug Master File) is a document detailing the whole manufacturing process of Mk2048 active pharmaceutical ingredient (API) in detail. Different forms of Mk2048 DMFs exist exist since differing nations have different regulations, such as Mk2048 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mk2048 DMF submitted to regulatory agencies in the US is known as a USDMF. Mk2048 USDMF includes data on Mk2048's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mk2048 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mk2048 suppliers with USDMF on PharmaCompass.
Mk2048 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mk2048 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mk2048 GMP manufacturer or Mk2048 GMP API supplier for your needs.
A Mk2048 CoA (Certificate of Analysis) is a formal document that attests to Mk2048's compliance with Mk2048 specifications and serves as a tool for batch-level quality control.
Mk2048 CoA mostly includes findings from lab analyses of a specific batch. For each Mk2048 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mk2048 may be tested according to a variety of international standards, such as European Pharmacopoeia (Mk2048 EP), Mk2048 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mk2048 USP).
LOOKING FOR A SUPPLIER?
